Showing 38,481 - 38,500 results of 99,991 for search '(( 5 we decrease ) OR ( 5 ((step decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.97s Refine Results
  1. 38481

    Enhanced Conductivity and Magnetic Ordering in Isostructural Heavy Atom Radicals by Craig M. Robertson (1533145)

    Published 2008
    “…Thermal activation energies <i>E</i><sub>act</sub> follow a similar profile, decreasing with increasing selenium content along the series <b>1a</b> (0.43 eV), <b>3a</b> (0.31 eV), <b>2a</b> (0.27 eV), <b>4a</b> (0.19 eV). …”
  2. 38482
  3. 38483
  4. 38484
  5. 38485
  6. 38486

    Table_1_BNP as a New Biomarker of Cardiac Thyroid Hormone Function.DOCX by Kaihao Wang (9100646)

    Published 2020
    “…Myocardial BNP mRNA was increased 2.5-fold in Hypo rats and its expression was decreased to normal values by 14 days of T3 treatment. …”
  7. 38487
  8. 38488

    Orchio-Septopexy: A new technique to cover and fix detorsed testis undergoing fasciotomy of tunica albuginea by Mohammed Elifranji (13160309)

    Published 2022
    “…Results Orchio-septopexy was performed in 11 cases with a mean age of 11.9 years (3-17). All cases had clinic follow-up and testicular Doppler US with a mean of 9.5 months (6-24). 6/11 cases (54%) were salvaged, with good vascularity in the Doppler US and maintained more than 50% testicular volume compared to the contralateral side. …”
  9. 38489

    Interaction of meropenem with ‘N’ and ‘B’ isoforms of human serum albumin: a spectroscopic and molecular docking study by Md. Tabish Rehman (355007)

    Published 2015
    “…Here, we investigated the interaction between meropenem and HSA at physiological pH 7.5 (N-isoform HSA) and non-physiological pH 9.2 (B-isoform HSA). …”
  10. 38490

    Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

    Published 2014
    “…The X-ray and atomic force microscopic investigations of “3,6-di­(2,2′-bithio­phen-5-yl)­pyrrolo­[3,4-<i>c</i>]­pyrrole-1,4-(2<i>H</i>,5<i>H</i>)-dione” (DPP-4T) synthesized from its precursor (di-<i>tert</i>-butyl-3,6-di­(2,2′-bithio­phen-5-yl)-1,4-dioxo­pyrrolo­[3,4-<i>c</i>]­pyrrole-2,5-(1<i>H</i>,4<i>H</i>)-dicarboxylate) through thermal conversion reveals that the solubilizing group removal rate plays a crucial role on the ultimate grain size and crystallinity of the final compound (DPP-4T). …”
  11. 38491

    Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

    Published 2014
    “…The X-ray and atomic force microscopic investigations of “3,6-di­(2,2′-bithio­phen-5-yl)­pyrrolo­[3,4-<i>c</i>]­pyrrole-1,4-(2<i>H</i>,5<i>H</i>)-dione” (DPP-4T) synthesized from its precursor (di-<i>tert</i>-butyl-3,6-di­(2,2′-bithio­phen-5-yl)-1,4-dioxo­pyrrolo­[3,4-<i>c</i>]­pyrrole-2,5-(1<i>H</i>,4<i>H</i>)-dicarboxylate) through thermal conversion reveals that the solubilizing group removal rate plays a crucial role on the ultimate grain size and crystallinity of the final compound (DPP-4T). …”
  12. 38492

    Nutritional profile of patients in a multidisciplinary treatment program for severe obesity and preoperative bariatric surgery by Fernanda Cristina Carvalho Mattos MAGNO (6380201)

    Published 2021
    “…It was observed that in the 5th appointment more than 50% of the patients underwent six meals a day. …”
  13. 38493

    Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics by Luca Rossetti (711357)

    Published 2015
    “…During follow-up the IOP decreased by 14% in these eyes but MD deteriorated by 1.1±3.5 dB/year, which was 5-fold higher than controls (0.2±1.6 dB/year). …”
  14. 38494
  15. 38495
  16. 38496
  17. 38497
  18. 38498

    Auditory phenotype and immunohistochemical analysis of Fhod3-TG mice. by Ely Cheikh Boussaty (17471493)

    Published 2024
    “…The survival rate of OHC in TG mice at the basal turn cochlea was significantly decreased compared to the WT control (WT vs TG (%): (IHC)100 vs 100 at apical turn (Api), 98.7± 0.95 vs 97.7±1.51 at middle turn (Mid), 94.7±2.24 vs 85.9±6.90 at basal turn (Base); (OHC) 97.1±1.16 vs 95±2.56 at Api, 96.8±0.36 vs 96.5±1.42 at Mid, 95.6±0.64 vs 75.93±8.98 at base, p* = 0.0233 by two-way ANOVA followed by a Tukey post-hoc test) (WT vs TG in the basal OHC (%): 95.6±0.64 vs 75.93±8.98, <i>p*</i> = 0.023 by Mann-Whitney U test, n = 4). …”
  19. 38499
  20. 38500

    Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

    Published 2023
    “…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”